查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1698157

生物製藥物流市場－全球產業規模、佔有率、趨勢、機會和預測（按服務、營運類型、區域和競爭細分，2020-2030 年）

Bio-Pharma Logistics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Service, By Type of Operation Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球生物製藥物流市場價值為 803.6 億美元，預計在預測期內將實現強勁成長，到 2030 年的複合年成長率為 7.16%。全球生物製藥物流市場是一個充滿活力且快速發展的行業，在製藥和生物技術行業中發揮關鍵作用。它涵蓋生物製藥產品（包括疫苗、藥品、生物製劑和臨床試驗材料）的儲存、運輸和分銷的規劃、執行和管理。該市場受到幾個關鍵因素的推動，包括對生物製藥產品的需求不斷增加、製藥供應鏈的全球化以及對專門的溫控和時間敏感的物流解決方案的需求，以保持敏感生物製藥產品的完整性。

市場概覽
預測期 2026-2030
2024年市場規模 803.6億美元
2030年市場規模 1207.1億美元
2025-2030 年複合年成長率 7.16%
成長最快的領域 冷鏈
最大的市場 北美洲

全球生物製藥物流市場的主要驅動力之一是生物製藥產品需求的不斷成長。隨著生物技術和製藥研究的進步導致藥物更加複雜和個人化，對可靠、高效的物流服務來運輸和儲存這些產品的需求至關重要。新冠疫情凸顯了強大供應鏈的重要性，以確保在全球範圍內及時交付疫苗和治療藥物。

關鍵市場促進因素

生物製藥產品需求不斷成長

主要市場挑戰

溫度控制和監測

主要市場趨勢

溫控物流

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：全球生物製藥物流市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按服務（運輸、倉儲及配送、加值服務）
    • 依操作類型（冷鏈、非冷鏈）
    • 按地區
    • 按公司分類（2024）
  • 市場地圖
    • 按服務
    • 按營運類型
    • 按地區

第5章：亞太生物製藥物流市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 按服務
    • 按營運類型
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 澳洲
    • 日本
    • 韓國

第6章：歐洲生物製藥物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 西班牙
    • 義大利
    • 英國

第7章：北美生物製藥物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 墨西哥
    • 加拿大

第8章：南美洲生物製藥物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 阿根廷
    • 哥倫比亞

第9章：中東和非洲生物製藥物流市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 埃及

第10章：市場動態

  • 驅動程式
  • 挑戰

第 11 章：市場趨勢與發展

  • 最新動態
  • 產品發布
  • 併購

第 12 章：全球生物製藥物流市場：SWOT 分析

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Kerry Logistics Network Limited
  • Deutsche Post AG
  • DHL Group
  • Kuehne + Nagel International AG
  • UPS (Marken) Inc.
  • DB Schenker
  • FedEx Corp.
  • Nippon Express Co Ltd
  • World Courier Inc.
  • SF Express

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 20292

Global Bio-Pharma Logistics Market was valued at USD 80.36 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 7.16% through 2030. The Global Bio-Pharma Logistics Market is a dynamic and rapidly evolving sector that plays a critical role in the pharmaceutical and biotechnology industries. It encompasses the planning, execution, and management of the storage, transportation, and distribution of biopharmaceutical products, including vaccines, pharmaceuticals, biologics, and clinical trial materials. This market is driven by several key factors, including the increasing demand for biopharmaceutical products, the globalization of the pharmaceutical supply chain, and the need for specialized temperature-controlled and time-sensitive logistics solutions to maintain the integrity of sensitive biopharmaceutical products.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 80.36 Billion
Market Size 2030USD 120.71 Billion
CAGR 2025-20307.16%
Fastest Growing SegmentCold Chain
Largest MarketNorth America

One of the major drivers of the Global Bio-Pharma Logistics Market is the growing demand for biopharmaceutical products. As advancements in biotechnology and pharmaceutical research lead to the development of more complex and personalized medicines, the need for reliable and efficient logistics services to transport and store these products is paramount. COVID-19 pandemic has underscored the importance of a robust supply chain to ensure the timely delivery of vaccines and therapeutic drugs on a global scale.

Key Market Drivers

Increasing Demand for Biopharmaceutical Products

The increasing demand for biopharmaceutical products is a pivotal factor driving the growth of the Global Bio-Pharma Logistics Market. Biopharmaceuticals, which include vaccines, monoclonal antibodies, gene therapies, and other advanced therapeutic modalities, have gained significant traction in recent years due to their remarkable efficacy in treating a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. This surge in biopharmaceutical development has catalyzed a corresponding need for efficient and specialized logistics solutions to ensure that these products are manufactured, transported, and distributed seamlessly across the globe. For instance, according to data from the Medical Logistics Branch of the China Federation of Things, the cold vaccine chain market in 2021 was valued at approximately CNY 48.14 billion (USD 7 billion), reflecting a year-on-year growth of 23.3%. In recent years, China has heavily invested in enhancing the development of cold vaccine chains and nationwide traceability systems.

Key Market Challenges

Temperature Control and Monitoring

Temperature control and monitoring pose a significant challenge to the Global Bio-Pharma Logistics Market. Biopharmaceutical products, including vaccines, biologics, gene therapies, and other advanced therapeutics, are highly sensitive to temperature fluctuations. Ensuring that these products are transported and stored under precise temperature conditions is essential to maintain their integrity, safety, and efficacy. The inability to address this challenge effectively can have far-reaching consequences for both the pharmaceutical industry and patient health.

One of the primary issues facing the bio-pharma logistics sector is the need for maintaining a consistent temperature throughout the entire supply chain. These products often require stringent temperature control, with variations outside the specified range potentially rendering them ineffective or even dangerous to patients. Achieving this level of temperature control presents several challenges.

The transportation of biopharmaceuticals involves a complex and multifaceted network of providers, including manufacturers, carriers, distribution centers, and healthcare facilities. Each of these entities must adhere to strict temperature requirements to ensure product quality. Any lapse in temperature control at any point along the supply chain can jeopardize the safety and efficacy of the products.

Key Market Trends

Temperature-Controlled Logistics

Temperature-controlled logistics plays a pivotal role in boosting the Global Bio-Pharma Logistics Market. This key trend addresses one of the most critical challenges facing the pharmaceutical and biotechnology sectors: the need to ensure the safe and effective transportation of temperature-sensitive biopharmaceutical products. As the demand for vaccines, biologics, gene therapies, and other advanced therapeutic modalities continues to grow, the necessity for maintaining precise temperature conditions throughout the supply chain has never been more significant. For instance, India ranks among the top 12 biotechnology destinations globally. In 2021, the country witnessed a significant surge in biotech startup registrations, with approximately 1,128 new startups registered-the highest in a single year since 2015. By the end of 2021, the total number of biotechnology startups reached 5,365, with projections suggesting this figure will rise to 10,000 by 2024. India is home to 665 FDA-approved plants in the U.S., accounts for 44% of global abbreviated new drug applications (ANDA), and has over 1,400 manufacturing plants meeting WHO standards. Also, India is the world's third-largest producer of the recombinant Hepatitis B vaccine.

Key Market Players

  • Kerry Logistics Network Limited
  • Deutsche Post AG
  • DHL Group
  • Kuehne + Nagel International AG
  • UPS (Marken) Inc.
  • DB Schenker
  • FedEx Corp
  • Nippon Express Co Ltd
  • World Courier Inc
  • SF Express

Report Scope:

In this report, the Global Bio-Pharma Logistics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bio-Pharma Logistics Market, By Service:

  • Transportation
  • Warehousing and Distribution
  • Value Added Services

Bio-Pharma Logistics Market, By Type of Operation:

  • Cold Chain
  • Non-cold Chain

Bio-Pharma Logistics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bio-Pharma Logistics Market.

Available Customizations:

Global Bio-Pharma Logistics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Bio-Pharma Logistics Market Outlook

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share & Forecast
    • 4.2.1. By Service (Transportation, Warehousing and Distribution, Value Added Services)
    • 4.2.2. By Type of Operation (Cold Chain, Non-cold Chain)
    • 4.2.3. By Region
    • 4.2.4. By Company (2024)
  • 4.3. Market Map
    • 4.3.1. By Service
    • 4.3.2. By Type of Operation
    • 4.3.3. By Region

5. Asia Pacific Bio-Pharma Logistics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Service
    • 5.2.2. By Type of Operation
    • 5.2.3. By Country
  • 5.3. Asia Pacific: Country Analysis
    • 5.3.1. China Bio-Pharma Logistics Market Outlook
      • 5.3.1.1. Market Size & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share & Forecast
        • 5.3.1.2.1. By Service
        • 5.3.1.2.2. By Type of Operation
    • 5.3.2. India Bio-Pharma Logistics Market Outlook
      • 5.3.2.1. Market Size & Forecast
        • 5.3.2.1.1. By Value
      • 5.3.2.2. Market Share & Forecast
        • 5.3.2.2.1. By Service
        • 5.3.2.2.2. By Type of Operation
    • 5.3.3. Australia Bio-Pharma Logistics Market Outlook
      • 5.3.3.1. Market Size & Forecast
        • 5.3.3.1.1. By Value
      • 5.3.3.2. Market Share & Forecast
        • 5.3.3.2.1. By Service
        • 5.3.3.2.2. By Type of Operation
    • 5.3.4. Japan Bio-Pharma Logistics Market Outlook
      • 5.3.4.1. Market Size & Forecast
        • 5.3.4.1.1. By Value
      • 5.3.4.2. Market Share & Forecast
        • 5.3.4.2.1. By Service
        • 5.3.4.2.2. By Type of Operation
    • 5.3.5. South Korea Bio-Pharma Logistics Market Outlook
      • 5.3.5.1. Market Size & Forecast
        • 5.3.5.1.1. By Value
      • 5.3.5.2. Market Share & Forecast
        • 5.3.5.2.1. By Service
        • 5.3.5.2.2. By Type of Operation

6. Europe Bio-Pharma Logistics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Service
    • 6.2.2. By Type of Operation
    • 6.2.3. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. France Bio-Pharma Logistics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Service
        • 6.3.1.2.2. By Type of Operation
    • 6.3.2. Germany Bio-Pharma Logistics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Service
        • 6.3.2.2.2. By Type of Operation
    • 6.3.3. Spain Bio-Pharma Logistics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Service
        • 6.3.3.2.2. By Type of Operation
    • 6.3.4. Italy Bio-Pharma Logistics Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Service
        • 6.3.4.2.2. By Type of Operation
    • 6.3.5. United Kingdom Bio-Pharma Logistics Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Service
        • 6.3.5.2.2. By Type of Operation

7. North America Bio-Pharma Logistics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Service
    • 7.2.2. By Type of Operation
    • 7.2.3. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Bio-Pharma Logistics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Service
        • 7.3.1.2.2. By Type of Operation
    • 7.3.2. Mexico Bio-Pharma Logistics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Service
        • 7.3.2.2.2. By Type of Operation
    • 7.3.3. Canada Bio-Pharma Logistics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Service
        • 7.3.3.2.2. By Type of Operation

8. South America Bio-Pharma Logistics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Service
    • 8.2.2. By Type of Operation
    • 8.2.3. By Country
  • 8.3. South America: Country Analysis
    • 8.3.1. Brazil Bio-Pharma Logistics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Service
        • 8.3.1.2.2. By Type of Operation
    • 8.3.2. Argentina Bio-Pharma Logistics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Service
        • 8.3.2.2.2. By Type of Operation
    • 8.3.3. Colombia Bio-Pharma Logistics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Service
        • 8.3.3.2.2. By Type of Operation

9. Middle East and Africa Bio-Pharma Logistics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Service
    • 9.2.2. By Type of Operation
    • 9.2.3. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. South Africa Bio-Pharma Logistics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Service
        • 9.3.1.2.2. By Type of Operation
    • 9.3.2. Saudi Arabia Bio-Pharma Logistics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Service
        • 9.3.2.2.2. By Type of Operation
    • 9.3.3. UAE Bio-Pharma Logistics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Service
        • 9.3.3.2.2. By Type of Operation
    • 9.3.4. Egypt Bio-Pharma Logistics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Service
        • 9.3.4.2.2. By Type of Operation

10. Market Dynamics

  • 10.1. Drivers
  • 10.2. Challenges

11. Market Trends & Developments

  • 11.1. Recent Developments
  • 11.2. Product Launches
  • 11.3. Mergers & Acquisitions

12. Global Bio-Pharma Logistics Market: SWOT Analysis

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Product

14. Competitive Landscape

  • 14.1. Kerry Logistics Network Limited
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Current Capacity Analysis
    • 14.1.5. Financials (In case of listed)
    • 14.1.6. Recent Developments
    • 14.1.7. SWOT Analysis
  • 14.2. Deutsche Post AG
  • 14.3. DHL Group
  • 14.4. Kuehne + Nagel International AG
  • 14.5. UPS (Marken) Inc.
  • 14.6. DB Schenker
  • 14.7. FedEx Corp.
  • 14.8. Nippon Express Co Ltd
  • 14.9. World Courier Inc.
  • 14.10.SF Express

15. Strategic Recommendations

16. About Us & Disclaimer